BPC/TB500 Blend: Handling, Storage, and Reconstitution Guide

This guide covers laboratory handling, storage, and reconstitution of the BPC/TB500 blend, a lyophilized co-formulation of two research peptides. Every step below is framed as laboratory best practice for in-vitro and animal-model preparation, not as human-use instruction.

Blend Handling and Storage Fundamentals

The BPC/TB500 blend ships as a solid, white lyophilized powder in a sealed glass vial containing both peptides. Store the lyophilized material at or below 25 degrees Celsius, sealed, and protected from heat, light, and moisture. For extended storage, keep it lyophilized and refrigerated or frozen. Because two components share the vial, consistent conditions protect both simultaneously.

Puritide offers the blend in 5+5 mg and 10+10 mg vials, where the two numbers indicate the milligram amount of each peptide.

Handling a two-peptide co-formulation adds a layer of bookkeeping relative to a single compound, since both components must be tracked from receipt through preparation and disposal. The physical handling steps are conventional, but the documentation must consistently reflect that two distinct molecules share the vial.

Account for Both Components

The blend combines BPC-157 (formula C62H98N16O22, free-acid weight about 1419.5 g/mol, CAS 137525-51-0) and TB-500 (formula C38H68N10O14, about 889.0 g/mol, CAS 885340-08-9). When calculating exposure, treat each component separately using the milligram amount indicated by the size notation. This dual accounting underpins the study designs in the BPC/TB500 blend research applications.

Reconstitution for In-Vitro Preparation

Reconstitute the blend with bacteriostatic water or another solvent appropriate to the assay. Add the diluent slowly down the inner wall of the vial rather than onto the powder, and allow both peptides to dissolve gently. Swirl; do not vortex aggressively or shake.

• Introduce diluent against the vial wall, not onto the pellet.
• Allow gentle, complete dissolution of both components.
• Inspect the solution before use.
• Compute each component's concentration from its labeled mass and the diluent volume.

Aliquoting to Limit Freeze-Thaw

Divide the reconstituted blend into single-use aliquots so each experiment draws from a vial thawed only once. Label each aliquot with both component amounts, concentration, date, and lot number. Minimizing freeze-thaw cycles preserves consistent exposure for combination studies, in line with the BPC-157 handling guide and the TB-500 handling guide.

Cold-Chain and Working-Solution Storage

Store reconstituted aliquots frozen for longer holds, and keep short-term working solutions cold and protected from light. Maintain consistent conditions throughout the study and monitor storage records. Because combination studies depend on stable, comparable exposure of both peptides, cold-chain discipline is especially important here.

Dual COA and Lot Verification

Each blend batch ships with a third-party-verified certificate of analysis providing identity and purity confirmation for both components (HPLC / reverse-phase chromatography and mass spectrometry), along with lot, blend composition, testing date, and method details. Verify both components on the COA against the vial label and retain the document. Sample COAs can be requested ahead of purchase.

PPE and Institutional Compliance

Handle the blend as an investigational material. Follow institutional SOPs, chemical hygiene plans, and approved protocols; wear a lab coat, gloves, and eye protection; and use engineering controls where required. All handling should be performed by qualified personnel in controlled environments. The blend mechanism overview and the BPC/TB500 blend product page provide specification context.

At intake, verify both components against their recorded synonyms and confirm the co-formulated white lyophilized appearance. Because the size notation encodes each peptide's mass, checking that the label matches the certificate of analysis for both molecules at receipt prevents the most common source of error in combination-study preparation.

Recording Both Components

Documentation for the blend must account for both peptides. A complete record notes the milligram amount of BPC-157 and of TB-500, the total diluent volume, and the resulting concentration of each component, along with the vial lot and its certificate of analysis. Because the analytical data covers two molecules, the record should reference both identities explicitly.

This dual record is what makes combination studies reproducible. When a later team wants to repeat a result, they need to know not just that a blend was used but the exact amount and concentration of each component, so the same combined exposure can be recreated. Treating the two peptides as separate entries in the log supports that precision.

Consistent handling is ultimately a reproducibility measure. A BPC/TB500 Blend preparation that is verified against its certificate of analysis, reconstituted gently, aliquoted to limit freeze-thaw, stored under stable cold-chain conditions, and fully documented gives every downstream experiment the same reliable starting material. That consistency is what allows independent laboratories to compare results and build on one another's work with confidence. When a study later proves difficult to reproduce, a complete handling record is often what lets investigators distinguish a genuine biological difference from a preparation artifact, which is why the effort invested in disciplined BPC/TB500 Blend handling repays itself throughout a project.

For research use only. These handling notes describe laboratory practice for the BPC/TB500 blend as a research material supplied by Puritide Research. It is not approved for human or veterinary use, and nothing here constitutes medical or administration guidance.